Project Scope This project team will define best practices for ensuring that similar types of adverse events are considered together for purposes of safety analyses. This project will develop efficient standardised processes and analyses that can leverage new technologies. |
| Project Leads | Emails |
|---|---|
| Mary Nilsson | |
| Greg Ball | gball@novavax.com |
| Objectives & Deliverables |
|---|
| White Paper |
| Journal Article |
| ||||||
|---|---|---|---|---|---|---|
| New project for Q22022 |
| Project Members | Organisation |
|---|---|
| Nhi Beasley | FDA |
| Rebeka Revis | IQVIA |
| Scott Proestel | FDA |
| Vaishali Popat | FDA |